Abstract
Advances in molecular biology are making it possible to develop assays for imaging specific molecular processes, including those directly related to gene expression. Imaging gene expression entails determining the location(s) of those cells expressing a particular gene of interest, as well as monitoring the magnitude and persistence of gene expression. The gene of interest may be an endogenous gene or it may be an “exogenous” gene introduced into the organism/ tissue(s) of interest. Imaging gene expression with generalized approaches applicable to any gene of interest have recently been reported. Conventional nuclear imaging techniques can be used to image gene expression if a radiolabeled substrate can be developed to interact with the protein of the gene of interest. However, more general methods are emerging to image gene expression without the need for developing new radiolabeled substrates for each new gene of interest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agrawal S and Iyer RP (1997) Perspectives in antisense therapeutics. Pharmacology and Therapeutics 76:151–60.
Alauddin MM, Raman RK, Kundun R, et al (1997) Evaluation of F-18 9[(3-[18F]fluoro-l-hydroxy-2-propoxy)methyl]gua-nine (F-18 FHPG) in HT-29 cells. Journal of Nuclear Medicine 38:176P.
Alrabiah FA and Sacks SL (1996) New Anti-herpes virus agents: their targets and therapeutic potential. Drugs 52:17–32.
Arner ES and Eriksson S (1995) Mammalian deoxyribonucle-oside kinases. Pharmacology and Therapeutics 67:155–186.
Bading JR, Alauddin MM, Fissekis JD, et al. (1997) Pharmacokinetics of F-18 fluorohydroxy-propoxymethylguanine (FHGP). Journal of Nuclear Medicine 38:43P.
Barrio JB, Satyamurthy N, Huang SC, et al (1989) 3-(2’-[18F]fluoroethyl)spiperone: In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. Journal of Cerebral Blood Flow and Metabolism 9:830–839.
Bogdanov A and Weissleder R (1998) The development of in vivo imaging systems to study gene expression. Trends in biotechnology 16:5–10.
Bunzow JR, Van Tol HH, Grandy DK, et al. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 367:783–787.
Cammilleri S, Sangrajrang S, Perderau B, et al. (1996) Biodistribution of iodine-125 dyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumor xenograft following intratumoral injection. European Journal of Nuclear Medicine 23:448–452.
Chalfie M, Tu Y, Euskirchen W, et al (1994) Green fluorescent protein as a marker for gene expression. Science 263:802–805.
Charlton J, Sennello J and Smith D (1997) In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chemistry and Biology 4:809–816.
Cherry SR, Shao Y, Silverman RW, et al. (1997) MicroPET: A high resolution PET scanner for imaging small animals. IEEE Transactions on Nuclear Science 44:1161–1166.
Conrad RC, Baskerville S and Ellington AD (1995) In vitro selection methodologies to probe RNA function and structure. Molecular Diversity 1:69–78.
Cotten M, Wagner E and Birnstiel M (1993) Receptor-mediated transport of DNA into eukaryotic cells. Methods in En-zymology 217:618–644.
Crooke S (1997) Progress in antisense therapeutics discovery and development. CIBA Foundation Symposium 209:158–168.
Crooke ST (1995) Progress in antisense therapeutics. Hematologic Pathology 9:59–72.
Crooke ST and Lebleu B (1993) Antisense Research and Applications. CRC Press, Inc., Ann Arbor, pp 579.
De Clercq E (1993) Antivirals for the treatment of herpes virus infections. J. Antimicrob. Chemother. 32:121–132.
Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, et al (1994) Noninvasive imaging of c-myc oncogene messenger RNA with indium-111 -antisense probes in a mammary tumor-bearing mouse model. J. of Nucl. Med. 35:1054–1063.
Ehrin E, Farde L, de Paulis T, et al (1985) Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. International Journal of Applied Radiation and Isotopes 36:269–273.
Elion GB (1993) Acyclovir: discovery, mechanism of action, and selectivity. Journal of Medical Virology 2–6.
Enochs WS, Petherick P, Bogdanova A, et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423.
Gallardo HF, Tan C and Sadelain M (1997) The internal riboso-mal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphyocytes. Gene Therapy 4:1115–1119.
Gambhir SS, Barrio J, Wu L, et al (1998) Imaging of Adenoviral Directed Herpes Simplex Virus Type 1 Thymidine Kinase Gene Expression in Mice with Ganciclovir. Journal of Nuclear Medicine 39:2003–2011.
Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR (1999a) Imaging Adenoviral-Directed Reporter Gene Expression in Living Animals with Positron Emission Tomography. Proc Natl Acad Sci (USA), 96(5):2333–2338.
Gambhir SS, Barrio JR, Herschman HR, Phelps ME (1999b) Assays for Non-Invasive Imaging of Reporter Gene Expression. Nuclear Medicine and Biology, 26:481–490
Goldenberg DM (1997) Perspectives on oncologic imaging with radiolabeled antibodies. Cancer 80:2431–2435.
Good L and Nielsen PE (1997) Progress in developing PNA as a gene-targeted drug. Antisense and Nucleic Acid Drug Development 7:431–437.
Goodchild J (1989) Oligodeoxynucleotides: Antisense inhibitors of gene expression. Macmillan, London.
Haberkorn U, Oberdorfer F, Gebert J, et al (1996) Monitoring of gene therapy with cytosine deaminase: in vitro studies using 3H-5-fluorocytosine. Journal of Nuclear Medicine 37:87–94.
Haider N, Iyer RR and Narula J (1998) Topics in Molecular Biology: Techniques and Methods. Journal of Nuclear Cardiology 5:343–354.
Hargrove JL, Hulsey MG, Schmidt FH, et al (1990) A computer program for modeling kinetics of gene expression. BioTechniques 8:654–660.
Helene C and Toulme JJ (1989) Oligodeoxynucleotides: Anti-sense Inhibitors of Gene Expression. In Cohen JS (ed). Macmillan, London, pp 137–172.
Herz J and Gerard RD (1993) Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol in normal mice. Proceedings of the National Academy of Sciences USA 90:2812–2816.
Hnatowich DJ, Winnard PJ, Virzi F, et al. (1995) Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36:2306–2314.
Hu S, Shively L, Raubitschek A, et al. (1996) A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Research 56:3055–3061.
Jacobs WR, Barletta RG, Udani R, et al. (1993) Rapid assessment of drug susceptibilities of mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819–822.
Kastis GK, Barber HB, Barrett HH, et al. (1998) High resolution SPECT imager for three-dimensional imaging of small animals (abstract). Journal of Nuclear Medicine 39:9P.
Kessler RM, Ansari MS, de Paulis T, et al. (1991) High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamines. Journal of Nuclear Medicine 32:1593–1600.
Knoell DL and Yiu IM (1998) Human gene therapy for hereditary diseases. American Journal of Health-System Pharmacy 55:899–904.
Levenson VV, Transue ED and Roninson IB (1998) Internal ri-bosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers. Human Gene Therapy 9:1233–1236.
Lewin B (1994) Genes V. Oxford University Press, New York.
Loke SL, Stein CA, Zhang XH, et al. (1989) Characterization of oligonucleotide transport into living cells. Proceedings of the National Academy of Sciences USA 86:7595–7599.
MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman H (1999) Repetitive, Non-invasive Imaging of the Dopamine D2 Receptor as a Reporter Gene in Living Animals. Gene Therapy, 6:785–791
Matsukura M, Shinozuka K, Zon G, et al. (1978) Phosphoroth-ioate analogs of oligodeoxynucleotides: novel inhibitors of replication and cytopathic effects of human immunodeficiency virus (HIV). Proceedings of the National Academy of Sciences USA 84:7706–7710.
Miller N and Vile R (1995) Targeted vectors for gene therapy. FASEB Journal 9:190–199.
Misteli T and Spector D (1997) Applications of the green fluorescent protein in cell biology and biotechnology. Nature Biotechnology 15:961–964.
Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for prospective cancer control strategy. Cancer Res. 46:5276–5281.
Murakami A, Blake K and Miller PS (1985) Characterization of sequence-specific oligodeoxynucleoside methylphospho-nates and their interaction with rabbit globin mRNA. Biochemistry 24:.
Nishiyama T, Kawamura Y and Kawamoto Kea (1985) Antineoplastic effects of 5-fluorocytosine in combination with cy-tosine deaminase capsules. Cancer Res. 45:1753–1761.
Pan D, Gambhir SS, Toyokuni T, et al. (1998) Rapid synthesis of a 5’-Fluorinated Oligodeoxynucletoide: A model antisense probe for use in imaging with Positron Emission Tomography (PET). Bioorganic & Medicinal Chemistry Letters 8:1317–1320.
Phillips JA, Craig SJ, Bayley D, et al. (1997) Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochemical Pharmacology 54:657–668.
Rolland AP (1998) From genes to gene medicines: recent advances in nonviral gene delivery. Critical Reviews in Therapeutic Drug Carrier Systems 15:143–198.
Rosenfeld MA, Yoshimura K, Trapnell BC, et al. (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143–155.
Shao Y, Cherry SR, Member, IEEE, Farahani K, et al. (1997) Development of a PET Detector System Compatible with MRI/NMR Systems. IEEE Transactions on Nuclear Science 44:1167–1171.
Smith AE (1995) Viral vectors in gene therapy. Annual Review of Microbiology 49:807–838.
Stein CA and Cheng YC (1993) Antisense oligonucleotides as therapeutic agents-is the bullet really magical. Science 261:1004–1011.
Strange PG (1990) Aspects of the structure of the D2 dopamine receptor. Trends in Neurosciences 13:373–378.
Stratford-Perricaudet LD, Levrero M, Chasse J-F, et al (1990) Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Human Gene Therapy 1:241–256.
Tavitian B, Terrazzino S, Kühnast B, et al (1998) In vivo imaging of oligonucleotides with positron emission tomography. Nature Medicine 4:467–471.
Tjuvajev JG, Avril N, Oku T, et al. (1998) Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Research 58:4333–4341.
Tjuvajev JG, Finn R, Watanabe K, et al. (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Research 56:4087–4095.
Tjuvajev JG, Stockhammer G, Desai R, et al. (1995) Imaging the expression of transfected genes in vivo. Cancer Research 55:6126–6132.
Wagner HNJ, Burns HD, Dannais RF, et al. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science. 221:1264–1266.
Wagner RW and Flanagan WM (1997) Antisense technology and prospects for therapy of viral infections and cancer. Molecular Medicine Today 3:31–38.
Wallace PM, MacMaster JF, Smith VF, et al. (1994) Intratumoral generation of 5-fluorouracil mediated by an antibody-cyto-sine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res. 54:2719–2723.
Weissleder R, Simonova M, Bogdanova A, et al (1997) MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204:425–429.
Wickstrom E (1986) Oligodeoxynucleotide stability in subcellular extracts and culture media. J. Biochem. Biophys. Methods. 13:97–102.
Wu-Pong S, Weiss TL and Hunt AC (1992) Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharmaceutical Research 9:1010–1017.
Wu-Pong S, Weiss TL and Hunt AC (1994) Antisense c-myc oligonucleotide cellular uptake and activity. Antisense Research and Development 4:155–163.
Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Na-mavari M, Cherry SR, Phelps ME, Herschman, HR, Gambhir SS. Quantitation of Target Gene Expression by Imaging Reporter Gene Expression in Living Animals. Nature Medicine (in press)
Zamecnik PC, Goodchild J, Yaguchi Y, et al. (1986) Inhibition of replication of expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proceedings of the National Academy of Sciences USA 83:4143–4146.
Zamecnik PC and Stephenson M (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences USA 75:280–284.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gambhir, S.S. (2000). Imaging Gene Expression: Concepts and Future Outlook. In: Schiepers, C. (eds) Diagnostic Nuclear Medicine. Diagnostic Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06590-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-06590-7_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-06592-1
Online ISBN: 978-3-662-06590-7
eBook Packages: Springer Book Archive